Ledger.Open graph →
SEC Form D · filed July 2, 2020

Imbria Pharmaceuticals, Inc

Offering
$80.7M
Sold
$40.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Andrew C. Levin · Boston, MADirectorDavid-Alexandre C. Gros · Boston, MAExecJames C. Januzzi · Boston, MADirectorAndrew C. Levin · Rancho Santa Fe, CADirectorDavid-Alexandre C. Gros · Rancho Santa Fe, CAExecJames C. Januzzi · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗